Barclays Upgrades Sotera Health (SHC) to Overweight

Barclays analyst Luke Sergott upgraded Sotera Health (NASDAQ: SHC) from Underweight to Overweight with a price target of $22.00 (from $6.00).

For an analyst ratings summary and ratings history on Sotera Health click here. For more ratings news on Sotera Health click here.

Shares of Sotera Health closed at $8.64 yesterday.

You May Also Be Interested In

• Wolfe Research Upgrades Biogen (BIIB) to Outperform
• JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
• Legence Corp (LGN) PT Lowered to $100 at BTIG